1. Home
  2. NUVL vs EMBJ Comparison

NUVL vs EMBJ Comparison

Compare NUVL & EMBJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$105.11

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

EMBJ

Embraer S.A.

N/A

Current Price

$63.14

Market Cap

9.9B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NUVL
EMBJ
Founded
2017
1969
Country
United States
Brazil
Employees
N/A
20744
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
9.9B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
EMBJ
Price
$105.11
$63.14
Analyst Decision
Strong Buy
Buy
Analyst Count
16
1
Target Price
$134.75
$84.00
AVG Volume (30 Days)
616.4K
1.4M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
0.34%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,239.49
$13.60
P/E Ratio
N/A
$159.30
Revenue Growth
N/A
N/A
52 Week Low
$63.56
$54.28
52 Week High
$113.02
$80.75

Technical Indicators

Market Signals
Indicator
NUVL
EMBJ
Relative Strength Index (RSI) 55.49 45.76
Support Level $100.98 $60.76
Resistance Level $107.08 $65.81
Average True Range (ATR) 3.38 2.13
MACD 0.12 -0.38
Stochastic Oscillator 67.47 8.68

Price Performance

Historical Comparison
NUVL
EMBJ

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About EMBJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

Share on Social Networks: